Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunothera...
Published in CNS Oncology
Management of high-grade gliomas (HGGs) remains a complex challenge with an overall poor prognosis despite aggressive multimodal treatment. New translational research has focused on maximizing tumor cell eradication through improved tumor cell targeting while minimizing collateral systemic side effects. In particular, biological intratumoral therap...
